ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Malignancy"

  • 2019 American Transplant Congress

    The Response to Human Papillomavirus Vaccination in Pediatric Patients before and after Kidney Transplantation

    C. Nailescu1, R. D. Nelson2, K. Twombley3, P. S. Verghese4, A. S. Chishti5, M. Mills6, J. E. Slaven7, J. D. Mahan8, M. L. Shew1

    1Riley Hospital for Children, Indianapolis, IN, 2Primary Children’s Hospital, Salt Lake City, UT, 3MUSC Children’s Hospital, Charleston, SC, 4Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN, 5Kentucky Children’s Hospital, Lexington, KY, 6C.S. Mott Children’s Hospital, Ann Arbor, MI, 7Indiana University, Indianapolis, IN, 8Nationwide Children’s Hospital, Columbus, OH

    *Purpose: Kidney transplant (KT) recipients have an increased incidence of malignancies, including Human Papillomavirus (HPV)-associated cancers. Thus, HPV vaccines may have an important role in…
  • 2019 American Transplant Congress

    Clinical Outcomes of Using mTOR Inhibitors with Reduced Dose of Calcineurin Inhibitors in Lung Transplant Recipients: A Single Center Experience

    M. Frawley1, J. Leedy1, A. James1, A. Salter1, V. Rusanov2

    1Department of Pharmacy, UAB Hospital, Birmingham, AL, 2Division of Pulmonary, Allergy, and Critical Care Medicine, UAB Hospital, Birmingham, AL

    *Purpose: The use of mammalian target of rapamycin inhibitors (mTORi) in cardiothoracic transplantation has significantly increased over the past decade. Several recent clinical trials have…
  • 2019 American Transplant Congress

    Ex Vivo Resection And Autologous Liver Transplantation As Management Concept For Extensive Malignancy

    K. Bruestle1, A. Griesemer2, S. Lobritto2, M. Martinez2, J. Vittorio2, D. Yamashiro2, E. Bacha3, T. Kato2

    1Columbia Center for Translational Immunology, Columbia University, New York City, NY, 2Columbia Center for Liver Disease and Transplantation, Columbia University Medical Center, New York City, NY, 3Morgan Stanley Children's Hospital, Columbia University Medical Center, New York City, NY

    *Purpose: Neuroblastomas are rare neural crest derived tumors which contribute disproportionally to childhood morbidity and mortality. Surgical resection remains standard treatment, however adequate resection is…
  • 2019 American Transplant Congress

    Donor Derived Neoplasia: Will It Be a Risk after Clinical Pig Organ Xenotransplantation?

    A. Jagdale1, H. Iwase1, E. Klein2, D. Cooper1

    1Surgery, University of Alabama at Birmingham, Birmingham, AL, 2Surgery, University of Pittsburgh, Pittsburgh, PA

    *Purpose: The survival of the nonhuman primates with life-supporting pig kidney grafts has increased substantially (to >1 year). As clinical pig organ xenotransplantation draws closer,…
  • 2019 American Transplant Congress

    Insurance Status Impacts Treatment for Hepatocellular Carcinoma

    L. Sobotka1, A. Hinton2, L. Conteh1

    1Gastroenterology, Hepatology and Nutrition, The Ohio State Wexner Medical Center, Columbus, OH, 2The Ohio State University, Columbus, OH

    *Purpose: Previous studies have identified treatment disparities in the treatment of hepatocellular carcinoma (HCC) based on insurance status and provider. Recent studies have shown more…
  • 2019 American Transplant Congress

    The Impact of Acute Rejection in Heart Transplantation on Post-Transplant Malignancy

    K. Kamrani1, A. Okoh2, D. Hanos1, M. Camacho1, M. Zucker2, K. Clarke1

    1Dept. of Surgery, Newark Beth Israel Medical Center, Newark, NJ, 2Dept. of Medicine, Newark Beth Israel Medical Center, Newark, NJ

    *Purpose: Compared with the general population, an increased incidence of skin cancers and lymphomas have been shown in orthotopic heart transplant (OHT) recipients. However, the…
  • 2019 American Transplant Congress

    Post-Transplant Cancer and Graft Failure in Kidney Transplant Recipients

    J. Kim, J. Ha, S. Min, H. Lee, Y. Kim, S. Han

    Seoul National University Hospital, Seoul, Korea, Republic of

    *Purpose: As the long-term patient survival and graft survival rate are gradually increasing in kidney transplant (KT) recipients, the importance of cancer occurrence and proper…
  • 2019 American Transplant Congress

    Characteristics And Outcomes Of Early Onset Cancers After Kidney Transplantation

    W. Lim1, E. Au2, A. Krishnan1, G. Wong2

    1Sir Charles Gairdner Hospital, Perth, Australia, 2University of Sydney & Westmead Hospital, Sydney, Australia

    *Purpose: Incident cancers developing after kidney transplantation are associated with significant morbidity and mortality and therefore age-appropriate cancer screening is recommended to identify asymptomatic cancers…
  • 2019 American Transplant Congress

    Whole Body CT Imaging in Deceased Donor Screening

    J. W. Mensink1, R. A. Pol.2, W. N. Nijboer1, J. de Jonge3, K. M. Ooms - de Vries4, M. F. van der Jagt5, M. C. van de Poll6, I. P. Alwayn1, A. E. Braat1

    1Department of Surgery; Division of Transplantation, Leiden University Medical Center, Leiden, Netherlands, 2Department of Surgery; Division of Transplantation, University Medical Center Groningen, Groningen, Netherlands, 3Department of Surgery; Division of Transplantation, Erasmus Medical Center, Rotterdam, Netherlands, 4Dutch Transplant Foundation, Leiden, Netherlands, 5Department of Surgery; Division of Transplantation, University Medical Center St. Radboud, Nijmegen, Netherlands, 6Department of Surgery and Department of Intensive Care, Maastricht University Medical Center, Maastricht, Netherlands

    *Purpose: Using older (extended criteria) donors to increase the donor pool increases the risk of malignancies in the donor. Our aim was to analyze the…
  • 2018 American Transplant Congress

    Long-Term Risk of Solid Organ De Novo Malignancies after Liver Transplantation: A French National Study on 11226 Patients

    O. Seree, M. Altieri, J. Dumortier, GReF2.

    Réseau Régional de Cancérologie Onco-Basse Normandie, Herouville St-Clair, France; Service d'Hépato-Gastroentérologie, Nutrition et Oncologie Digestive, CHU CAEN Hôpital Côte de Nacre, Caen, France; Hospices Civils de Lyon, Lyon, France.

    Background and aims: De novo malignancies are one of the major late complications and cause of death after liver transplantation (LT). Using extensive data from…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences